Read article – Anthony Fauci, the nation’s top infectious disease expert, spoke with Dartmouth-Hitchcock and Geisel School of Medicine employees and students on a Monday Zoom call. Fauci addressed questions related to reopening schools, mask-wearing, and the potential for public acceptance of a COVID-19 vaccine. Joanne Conroy ’77, president and CEO of Dartmouth-Hitchcock, said Fauci accepted Dartmouth-Hitchcock’s invitation to take part in the conversation because James Strickler, emeritus dean of the Geisel School of Medicine, had previously studied and worked with him.

Read article – Continued coverage of a study led by William Hudenko, clinical assistant professor of psychology, which found that text messaging can be a feasible mental health support tool when used alongside normal care.

Read article – Cites comments by Stewart Tepper, professor of neurology, about the use of CGRP inhibitors for migraine treatment. Tepper’s comments are originally from an interview with the American Migraine Foundation. (Picked up by MSN.)

Read article – A feature story about Daniel Rifkin, MED ’92, who developed Ognomy, a new app that will allow providers at Sleep Medicine Centers of Western New York to examine patients by computer or smartphone, ship sleep study equipment, and arrange treatment if the study confirms sleep apnea.

Read article – Continued coverage of a study led by William Hudenko, clinical assistant professor of psychology, which found that text messaging, in addition to normal care, can be a feasible mental health support tool.

Read article – Quotes William Hudenko, clinical assistant professor of psychology, in a feature story about a study he led finding that interventions using text messaging can be effective to augment therapy services for patients with severe mental illness.

Read article – Continued coverage of news that Sharon Alroy-Preis, MED ’10 has been appointed head of public health for Israel’s Ministry of Health.

Read article – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, about how preliminary findings have flagged potential problems with some COVID-19 tests. “In the beginning, the FDA was under a lot of pressure to get these tests onto the marketplace,” said Woloshin. “But now that there are plenty of tests out there, it’s time for them to raise the bar.”

Read article – Quotes William Hudenko, clinical assistant professor of psychology, in a feature story about a study he led which found that combining a texting service with other treatments can be a viable way for consumers to see improvements in their mental health. “This study is very exciting because we saw real improvement in those who utilized the text messaging-based intervention on top of normal care,” says Hudenko. “This was true for individuals with some of the most serious forms of mental illness. The results are promising, and we anticipate that people with less severe psychopathology may even do better with this type of mobile intervention.”

Read article – Additional coverage of a study led by William Hudenko, clinical assistant professor of psychology, which found that text messaging, in addition to normal care, can be a feasible mental health support tool.